Policy issues in the development and adoption of biomarkers for molecularly targeted cancer therapies : workshop summary

Policy issues in the development and adoption of biomarkers for molecularly targeted cancer therapies workshop summary

Mostrar otras versiones (1)

"One of the challenges in treating cancer is the disease's complexity and variation among patients. Cancer manifests differently in each patient, so treatments that are effective in one patient may not be effective in another. As cancer care becomes more personalized, subpopulations of ind...

Descripción completa

Detalles Bibliográficos
Autor principal: Policy Issues in the Development and Adoption of Molecularly Targeted Therapies for Cancer (Workshop) (-)
Autores Corporativos: Policy Issues in the Development and Adoption of Molecularly Targeted Therapies for Cancer (Workshop) Corporate Author (corporate author), National Cancer Policy Forum (U.S.), issuing body (issuing body), Institute of Medicine (U.S.). Board on Health Care Services, issuing body
Otros Autores: Patlak, Margie, author (author), Nass, Sharyl J., author, Phillips, Jonathan, author
Formato: Libro electrónico
Idioma:Inglés
Publicado: Washington, District of Columbia : The National Academies Press [2015]
Edición:1st ed
Materias:
Cancer > Treatment > United States > Congresses.
Cancer > Genetic aspects > Congresses.
Biochemical markers > Congresses.
United States.
Ver en Biblioteca Universitat Ramon Llull:https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009816728206719
Descripción
Sumario:"One of the challenges in treating cancer is the disease's complexity and variation among patients. Cancer manifests differently in each patient, so treatments that are effective in one patient may not be effective in another. As cancer care becomes more personalized, subpopulations of individuals will be given preventive or therapeutic interventions based on their susceptibility to a particular disease or their predicted response to a specific treatment. However, before the use of personalized cancer care can reach its full potential, the health care system must resolve a number of technological, regulatory, and reimbursement issues. To explore these policy challenges, the National Cancer Policy Forum held the workshop Policy Issues in the Development of Personalized Medicine in Oncology in June 2009. Experts provided presentations on the current state of personalized medicine technology, as well as issues in the validation of, regulation of, and reimbursement for the predictive tests that underpin personalized medicine. Participants discussed the obstacles and possible solutions to further developing and using personalized medicine technologies. This document summarizes the workshop"--
Notas:Description based upon print version of record.
Descripción Física:1 online resource (100 p.)
Bibliografía:Includes bibliographical references.
ISBN:9780309368605
9780309368582

Ejemplares similares